Views & Analysis Jay Bradner: leading Novartis into age of digitally-enabled ... Jay Bradner, head of Novartis’ drug discovery, talks to pharmaphorum about the firm’s drive to transform itself into 'a medicine and data science company'.
Views & Analysis How AI, blockchain, and big data can reduce drug development... Cutting-edge technologies are increasingly improving pharma’s R&D processes.
News Medial EarlySign's AI scans medical records for kidney disea... A machine learning technology developed to spot dangerous medical conditions before they worsen has shown its value in a trial.
Views & Analysis Pharma R&D is crying out for disruption – is AI the answer? Artificial Intelligence (AI), big data and genomics are coming together to revolutionise drug discovery and development.
News Nearly half of life science professionals using AI - survey But lack of technical expertise holding back projects.
Events Partner Content Blockchain for Clinical Trials Forum Setting a New Standard for Optimizing Clinical Trials
News Europe is facing a surge in STIs, says ECDC Cases of sexually-transmitted infections (STIs) – particularly gonorrhoea and syphilis – are at record levels across 29 European countries.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.